CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income (loss)	$ 44,641	$ 97,915
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	285,057	295,734
Long-lived asset impairment	51,860	26,039
Amortization of deferred financing costs	4,602	4,702
Income from discontinued operations, net of tax	(37,743)	(54,499)
Amortization of debt discount	871	12,099
Provision for doubtful accounts	3,240	1,691
Gain on sale of property, plant and equipment	(2,227)	(5,582)
Equity in income of non-consolidated affiliates	(15,152)	(14,553)
Amortization of terminated interest rate swaps	2,721	3,470
Interest rate swaps	269	258
(Gain) loss on remeasurement of intercompany balances	35,550	(116)
Stock-based compensation expense	14,131	15,289
Deferred income tax provision	(38,091)	(15,450)
Changes in assets and liabilities, net of acquisitions:
Accounts receivable and notes	58,993	(43,328)
Inventory	23,457	(10,095)
Costs and estimated earnings versus billings on uncompleted contracts	(34,393)	(12,106)
Other current assets	(9,583)	(7,627)
Accounts payable and other liabilities	(51,748)	10,818
Deferred revenue	(9,494)	(22,445)
Other	(14,601)	(6,046)
Net cash provided by continuing operations	312,360	276,168
Net cash provided by discontinued operations	3,441	3,954
Net cash provided by operating activities	315,801	280,122
Cash flows from investing activities:
Capital expenditures	(350,253)	(385,739)
Proceeds from sale of property, plant and equipment	21,856	19,736
Payment for business acquisitions	0	(494,755)
Return of investments in non-consolidated affiliates	15,185	14,750
Proceeds received from settlement of note receivable	5,357	0
Increase in restricted cash	(1)	(245)
Cash invested in non-consolidated affiliates	(33)	(197)
Net cash used in continuing operations	(307,889)	(846,450)
Net cash provided by discontinued operations	33,119	49,835
Net cash used in investing activities	(274,770)	(796,615)
Cash flows from financing activities:
Proceeds from borrowings of long-term debt	1,055,000	1,849,799
Repayments of long-term debt	(1,006,500)	(1,406,000)
Payments for debt issuance costs	(3,208)	(6,923)
Payments above face value for redemption of convertible debt	0	(15,007)
Payments for settlement of interest rate swaps that include financing elements	(2,815)	(2,844)
Net proceeds from the sale of Partnership units	1,164	169,471
Proceeds from stock options exercised	1,106	11,637
Proceeds from stock issued pursuant to our employee stock purchase plan	910	1,324
Purchases of treasury stock	(3,771)	(6,372)
Dividends to Exterran stockholders	(31,167)	(30,047)
Stock-based compensation excess tax benefit	3,048	8,269
Distributions to noncontrolling partners in the Partnership	(61,045)	(54,893)
Net cash provided by (used in) financing activities	(47,278)	518,414
Effect of exchange rate changes on cash and cash equivalents	(976)	(3,797)
Net increase (decrease) in cash and cash equivalents	(7,223)	(1,876)
Cash and cash equivalents at beginning of period	39,739	35,665
Cash and cash equivalents at end of period	32,516	33,789
Supplemental disclosure of non-cash transactions:
Treasury shares issued for redemption of convertible debt	0	219,211
Shares acquired from exercise of call options	0	(89,407)
Shares issued for exercise of warrants	$ 88	$ 6,851